Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study

International Journal of Pharmaceutics

Volumn 174, Issue 1-2, 1998, Pages 47-54

  Iannuccelli, V ^a   Coppi, G ^a   Bernabei, M T ^a   Cameroni, R ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Calcium alginate; Floating ability; Floating dosage form; Multiple unit dosage form; Poly(vinyl alcohol); Porosity

Indexed keywords

CALCIUM ALGINATE; POLYVINYL ALCOHOL;

ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; MEAN RESIDENCE TIME; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; PREFORMULATION; PRIORITY JOURNAL; STOMACH JUICE;

EID: 0031764619     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00229-4     Document Type: Article

References (16)

1. Bhagat, H.R., Mendes, R.W., Mathiowitz, E., Bhargava, H.N., 1994. Kinetics and mechanism of drug release from calcium alginate membrane coated tablets. Drug Dev. Ind. Pharm. 20, 387-394.
2. Bodmeier, R., Chen, H., Paeratakul, O., 1989. A novel approach to the oral delivery of micro- or nanoparticles. Pharm. Res. 6, 413-417.
3. Bornemann, H., Hentschel, U., Pietschmann, E., 1983. Bestimmung des Wasseraufnahmevermögens an Pudergrundstoffen und Arzneifertigwaren, Pharmazeut. Praxis. 38, 153-155.
4. Chien, Y.W., 1992. Oral drug delivery. In: Chien, Y.W. (Ed.), Novel Drug Delivery Systems, Marcel Dekker, New York, pp. 139-196.
5. Desai, S., Bolton, S., 1993. A floating controlled-release drug delivery system: in vitro-in vivo evaluation. Pharm. Res. 10, 1321-1325.
6. Deshpande, A.A., Rhodes, C.T., Shah, N.H., Malick, A.W., 1996. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug. Dev. Ind. Pharm. 22, 531-539.
7. Grant, G.T., Morris, E.R., Rees, D.A., Smith, P.J.C., Thom, D., 1973. Biological interactions between polysaccharides and divalent cations: the egg-box model. Febs Letts. 32, 195-198.
8. Haug, N.A., 1959. Ion exchange properties of alginate fractions. Acta Chem. Scand. 13, 1250-1251.
9. Haug, N.A., Smidsrød, O., 1965. The effect of divalent metals on the properties of alginate solutions. II. Comparison of different metal ions. Acta Chem. Scand. 19, 341-351.
10. Iannuccelli, V., Coppi, G., Vandelli, M.A., Leo, E., Bernabei, M.T., 1995. Bead coating process via an excess of crosslinking agent. Drug Dev. Ind. Pharm. 21, 2307-2322.
11. Kawashima, Y., Niwa, T., Takeuchi, H., Hino, T., Itoh, Y., 1992. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 81, 135-140.
12. Kim, C.-K., Lee E.-J., 1992. The controlled release of blue dextran from alginate beads. Int. J. Pharm. 79, 11-19.
13. Oth, M., Franz, M., Timmermans, J. And Möes, A., 1992. The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol. Pharm. Res. 9, 298-302.
14. Porter, S.C., Ghebre-Sellassie, I., 1994. Key factors in the development of modified-release pellets. In: Ghebre-Sellassie, I. (Ed.), Multiparticulate Oral Drug Delivery, Marcel Dekker, New York, pp. 217-284.
15. Richardson, J.G., 1961. Flow through porous media. In: Streeter V.L. (Ed.), Handbook of Fluid Dynamics, McGraw-Hill Book Company, Inc., New York, Chap. 16, pp. 1-111.
16. Stockwell, A.F., Davis, S.S., Walker, S.E., 1986. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Controlled Release 3, 167-175.